News

Tuesday 28 October - Wednesday 29 October 2025 Auditorium, IGBMC

2025 ARRIGE Annual Meeting

Access and Affordability of Gene Therapies : Challenges for Genome Editing

🎯 Registration is now open !📅 October 28 & 29, 2025 (two half-days) 📍 Hybrid format – In-person at IGBMC, Strasbourg (France) & Online

Join us at ARRIGE annual meeting for a two half-day meeting exploring the pressing ethical, social, and policy issues surrounding access to and affordability of emerging gene therapies developed through genome editing technologies. The event will bring together researchers, clinicians, policy makers, regulators, biotech entrepreneurs, pharma and patient advocates to discuss equity, innovation, and global health implications.

🔗 Programme and key information👉https://www.arrige.org/portfolio/2025-arrige-annual-meeting/

 📝 Register now👉https://us06web.zoom.us/webinar/register/WN_HzSlttoAQh6wtA_xPChkmw#/registration

💶 Free for ARRIGE members (€50 annual fee) | €80 for non-members✈️ Travel discount available via AIR FRANCE/KLM – use event code GME60051AF

Confirmed Speakers:

• Paul Aliu, Novartis, Switzerland
• Fabiana Arzuaga, University of Buenos Aires, Argentina
• Alta Charo, University of Wisconsin, USA
• Marina Cavazzana, University of Paris Descartes, France
• Kazuto Kato, University of Osaka, Japan
• Kiran Musunuru, UPENN, USA
• Michael S Pepper, University of Pretoria, South Africa
• Pawel Lukow, University of Warsaw, Poland
• Julian März, University of Zürich, Switzerland
• Fyodor Urnov, UC Berkeley, USA

This event is sponsored by the University of Strasbourg

X